CUSIP 20030N101CL ACMCSAQ4 2025
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $0.60 | $0.60 | $31.46B | $2.17B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $0.91 | $0.90 | $31.20B | $3.33B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $2.99 | $2.98 | $30.31B | $11.12B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $0.90 | $0.89 | $29.89B | $3.38B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $0.94 | $0.94 | $32.07B | $3.63B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $1.01 | $1.00 | $29.69B | $3.93B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $0.97 | $0.97 | $30.06B | $3.86B | 10-Q |
| Sep 30, 2023 | Q3 2023 | $0.98 | $0.98 | $30.11B | $4.05B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $1.02 | $1.02 | $30.51B | $4.25B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $0.91 | $0.91 | $29.69B | $3.83B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $-1.05 | $-1.05 | $29.85B | $-4.60B | 10-Q |
| Jun 30, 2022 | Q2 2022 | $0.76 | $0.76 | $30.02B | $3.40B | 10-Q |